批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/06/16 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/09/11 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/10/11 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/02/02 |
SUPPL-9(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2017/12/22 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/11/15 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/10/28 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/10/26 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/07/27 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/03/16 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/16 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/12/23 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/06/05 |
SUPPL-7(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/06/21 |
SUPPL-6(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/11/24 |
SUPPL-5(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2010/11/24 |
SUPPL-3(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/06/30 |
ORIG-1(原始申请) |
Approval |
Type 2 - New Active Ingredient |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:FERUMOXYTOL 剂型/给药途径:SOLUTION;INTRAVENOUS 规格:EQ 510MG IRON/17ML (EQ 30MG IRON/ML) 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022180 |
001 |
NDA |
FERAHEME |
FERUMOXYTOL |
SOLUTION;INTRAVENOUS |
EQ 510MG IRON/17ML (EQ 30MG IRON/ML) |
Prescription |
Yes |
Yes |
AB |
2009/06/30
|
COVIS |
206604 |
001 |
ANDA |
FERUMOXYTOL |
FERUMOXYTOL |
SOLUTION;INTRAVENOUS |
EQ 510MG IRON/17ML (EQ 30MG IRON/ML) |
Prescription |
No |
No |
AB |
2021/01/15
|
SANDOZ |